IN202221054235A - - Google Patents

Download PDF

Info

Publication number
IN202221054235A
IN202221054235A IN202221054235A IN202221054235A IN202221054235A IN 202221054235 A IN202221054235 A IN 202221054235A IN 202221054235 A IN202221054235 A IN 202221054235A IN 202221054235 A IN202221054235 A IN 202221054235A IN 202221054235 A IN202221054235 A IN 202221054235A
Authority
IN
India
Application number
IN202221054235A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN202221054235A priority Critical patent/IN202221054235A/en
Priority to EP23793032.6A priority patent/EP4590277A1/en
Priority to CN202380065197.4A priority patent/CN119894500A/zh
Priority to PCT/IB2023/059391 priority patent/WO2024062443A1/en
Publication of IN202221054235A publication Critical patent/IN202221054235A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN202221054235A 2022-09-22 2022-09-22 IN202221054235A (enExample)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN202221054235A IN202221054235A (enExample) 2022-09-22 2022-09-22
EP23793032.6A EP4590277A1 (en) 2022-09-22 2023-09-22 Pharmaceutical compositions
CN202380065197.4A CN119894500A (zh) 2022-09-22 2023-09-22 药物组合物
PCT/IB2023/059391 WO2024062443A1 (en) 2022-09-22 2023-09-22 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202221054235A IN202221054235A (enExample) 2022-09-22 2022-09-22

Publications (1)

Publication Number Publication Date
IN202221054235A true IN202221054235A (enExample) 2023-11-03

Family

ID=88505108

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202221054235A IN202221054235A (enExample) 2022-09-22 2022-09-22

Country Status (4)

Country Link
EP (1) EP4590277A1 (enExample)
CN (1) CN119894500A (enExample)
IN (1) IN202221054235A (enExample)
WO (1) WO2024062443A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025160542A1 (en) * 2024-01-26 2025-07-31 Inesket Llc Ketamine nasal spray formulation and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4312016A1 (de) * 1993-04-13 1994-10-20 Goedecke Ag Stabile Ketamin-Lösungen
US20090156562A1 (en) * 2005-11-14 2009-06-18 Winch Peter D Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts
EP3968979A4 (en) * 2019-05-15 2023-03-01 Bexson Biomedical, Inc. KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
GB2596592A (en) 2020-07-03 2022-01-05 Alkaloid Ad Skopje Pharmaceutical formulation
WO2022109050A1 (en) 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025160542A1 (en) * 2024-01-26 2025-07-31 Inesket Llc Ketamine nasal spray formulation and methods of use

Also Published As

Publication number Publication date
EP4590277A1 (en) 2025-07-30
CN119894500A (zh) 2025-04-25
WO2024062443A1 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
IN202221054235A (enExample)
BR102023001987A2 (enExample)
BR102023001877A2 (enExample)
BR202022009269U2 (enExample)
BR202022005961U2 (enExample)
BR202022001779U2 (enExample)
BR202022000931U2 (enExample)
CN307044590S (enExample)
BY13165U (enExample)
CN307049732S (enExample)
CN307049445S (enExample)
BY13140U (enExample)
CN307048718S (enExample)
CN307048678S (enExample)
CN307048453S (enExample)
BY13139U (enExample)
CN307047408S (enExample)
CN307047266S (enExample)
CN307046898S (enExample)
CN307046355S (enExample)
CN307045863S (enExample)
CN307045611S (enExample)
CN307045182S (enExample)
CN307044935S (enExample)
BY13141U (enExample)